J. Seo

Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.

N. LeBoeuf, M. Asgari, V. Naranbhai, 2022, JAMA dermatology.

804 Real-world incidence and impact of pneumonitis in lung cancer patients treated with immune checkpoint inhibitors

R. Sullivan, K. Reynolds, V. Pahalyants, 2021, Journal for ImmunoTherapy of Cancer.

Biomechanical interplay between anisotropic re-organization of cells and the surrounding matrix underlies transition to invasive cancer spread

Kshitiz, M. Kwak, A. Levchenko, 2018, Scientific Reports.

Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study

J. Naidoo, K. Reynolds, M. Sise, 2022, Journal for ImmunoTherapy of Cancer.

Biomechanical interplay between anisotropic re-organization of cells and the surrounding matrix underlies transition to invasive cancer spread

Kshitiz, M. Kwak, A. Levchenko, 2018, Scientific Reports.

Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.

Shenmin Zhang, Kun‐Hsing Yu, G. Boland, 2023, Journal of American Academy of Dermatology.

Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study.

Shenmin Zhang, Kun‐Hsing Yu, G. Boland, 2023, Journal of the American Academy of Dermatology.

Surgeons' Views on Shared Decision-Making.

G. Geller, Z. Berger, E. Boss, 2020, Journal of patient-centered research and reviews.